Brief: NovaBay Pharmaceuticals Board Determines Unsolicited Offer Is Superior To Asset Purchase Agreement With PRN Physician Recommended Nutriceuticals, LLC
Oct 29 (Reuters) - NovaBay Pharmaceuticals Inc NBY.A :
* NOVABAY PHARMACEUTICALS BOARD DETERMINES UNSOLICITED OFFER
IS
SUPERIOR TO ASSET PURCHASE AGREEMENT WITH PRN PHYSICIAN
RECOMMENDED NUTRICEUTICALS, LLC
* NOVABAY PHARMACEUTICALS: UNDER REFRESH'S OFFER CO WOULD
RECEIVE
A PURCHASE PRICE OF UP TO $11.5 MILLION
* NOVABAY PHARMACEUTICALS: REFRESH'S OFFER ALSO INCLUDES
REFRESH
PROVIDING A SECURED TERM LOAN TO CO IN PRINCIPAL AMOUNT OF $2.0
MILLION
Source text: ID:nBw1bPX0Da
Further company coverage: NBY.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing